Publications
2025
The small molecule inhibitor 3PO is a modulator of neutrophil metabolism, ROS production and NET release.
Fresneda Alarcon, M., Abdullah, G. A., Nolan, A., Linford, C., Meschis, M. M., Cross, A. L., . . . Wright, H. L. (2025). The small molecule inhibitor 3PO is a modulator of neutrophil metabolism, ROS production and NET release.. Clinical and experimental immunology, uxaf012. doi:10.1093/cei/uxaf012
Hypoxia Dependent Inhibition of Glioblastoma Cell Proliferation, Invasion, and Metabolism by the Choline-Kinase Inhibitor JAS239.
Kelly, C. L., Wydrzynska, M., Phelan, M. M., Osharovich, S., Delikatny, E. J., Sée, V., & Poptani, H. (2025). Hypoxia Dependent Inhibition of Glioblastoma Cell Proliferation, Invasion, and Metabolism by the Choline-Kinase Inhibitor JAS239.. Metabolites, 15(2), 76. doi:10.3390/metabo15020076
2024
Serum metabolomics identifies unique inflammatory signatures to distinguish rheumatoid arthritis responders and non-responders to TNF inhibitor therapy
New Insights into Healthy Ageing, Inflammageing and Frailty using Metabolomics
Abdullah, G., Akpan, A., Phelan, M., & Wright, H. (2024). New Insights into Healthy Ageing, Inflammageing and Frailty using Metabolomics. Frontiers in Aging.
Diagnostic utility of clinicodemographic, biochemical and metabolite variables to identify viable pregnancies in a symptomatic cohort during early gestation.
Hill, C. J., Phelan, M. M., Dutton, P. J., Busuulwa, P., Maclean, A., Davison, A. S., . . . Hapangama, D. K. (2024). Diagnostic utility of clinicodemographic, biochemical and metabolite variables to identify viable pregnancies in a symptomatic cohort during early gestation.. Scientific reports, 14(1), 11172. doi:10.1038/s41598-024-61690-3